• To be able to perform specialist assessment, treatment and counselling of patients with head and neck cancer (H&NC), including prevention and human papilloma virus (HPV)-related issues

  • Awareness of the existence of different individual H&NC primary tumour sites with biological and pathological subtypes for the selection of the appropriate treatment strategies

  • Awareness of the availability of different diagnostic procedures

  • Awareness of the existence of H&NC-related prognostic factors such as age and HPV

  • Appreciation of the importance of the multimodality approach to treat patients with H&NC

  • Awareness of risk factor counselling and smoking cessation

  • Appreciation of the importance of viral aetiology in specific anatomical subsites

  • Familiarity with stage-based treatment approaches

  • Familiarity with recognising patients with or at risk of airway obstruction

  • Familiarity with the implications of the different subsites, histotypes and biological subtypes of H&NC for the selection of the appropriate treatment strategies

  • Familiarity with the risk assessment work-up, especially the staging system for H&NC

  • Familiarity with the indications and value of surgery, radiation therapy, chemotherapy and monoclonal antibodies in H&NC, but also with their limitations (eg, treatment-related sequelae)

  • Familiarity with preventive measures in preparation for multimodality treatment

  • Understanding of the role of chemotherapy and monoclonal antibodies in the management of patients with advanced disease

  • Understanding of the strengths of treatment personalisation opportunities and the importance of offering individualised treatment plans based on a global patient assessment (performance status, age, caregiver, nutritional status, patient preferences)

  • Understanding of the complications derived from treatment and disease progression in the context of being familiar with supportive and palliative care strategies

  • Understanding of the value of follow-up for rehabilitation

  • Ability to contribute actively to a variety of H&NC clinical scenarios and patient presentations

  • Ability to discuss critically the treatment options/recommendations

  • Ability to perform a history and physical examination in H&NC patients, including different subtypes

  • Ability to contribute to discussions on general management strategies in order to understand all the considerations on which treatment to use and which sequence to select for the multidisciplinary strategy

  • Ability to prescribe various therapeutic agents considering their potential interactions with radiation therapy

  • Ability to correctly advise organ-preservation strategies

  • Ability to evaluate conditions (such as performance status and patient's clinical condition, concomitant disease(s), previous treatments etc) that are important for considering whether and when to start and to stop treatment or to switch to another option

  • Ability to manage side effects of various chemotherapeutic agents and monoclonal antibodies as well as radiation therapy

  • Ability to discuss prevention strategies with patients

  • Ability to counsel about HPV related infections patients, partners and family